semaglutide and b12 injections + (Cyanocobalamin) | 10mL Multi-Dose Weight Loss Injection Is compounded semaglutide with B12

Semaglutide Semaglutide is a GLP-1 receptor agonist initially developed for type 2 diabetes, with growing clinical use in chronic weight management

Mechanism (for clinical insight) GLP-1 receptor agonist Appetite (central satiety) Gastric emptying Glucose-dependent insulin secretion Glucagon This mechanism underlies both glycemic benefit and weight reduction

Mutagenicity tests performed in Salmonella typhimurium, Saccharomyces cerevisiae, and Schizosaccharomyces pombe indicate that levocarnitine is not mutagenic

Safety and Tolerability of GLP-1-Based Therapies in Adolescents Despite their effectiveness, GLP-1, dual, and triple agonists have side effects that require careful management: Common Adverse Events Gastrointestinal Symptoms: Nausea (4261%)